Tesla (TSLA) Stock Upgraded by Morgan Stalney - $320 Price Target 2014

Tesla (TSLA) Upgraded w/ $320 Price Target in 2014 - @stockstobuy -

Tesla (TSLA) is rising to $230 in early pre market this morning after Morgan Stanley upgraded the stock with a 2014 price target of $320.  I tweeted this might happen yesterday and it looks like I was lucky on the timing.  Shorts are getting crushed and the latest victim has been CNBC guest Doug Kass.  Doug Kass tried to be a hero and short TSLA right before earnings which is something you should never do.  I doubt he will cover today so as long as shorts are holding on for dear life, Tesla shares will continue to rally.  It's when all shorts capitulate and cover, long term holders should be worried and be looking to sell.

Doughtery analyst Andrea James was the first person to upgrade Tesla (TSLA) with a $300+ price target after earnings last week.  She upgraded Tesla with a $325 price target.  Andrea James has been spot on for the past year when she predicted a $200 per share when TSLA was trading at $90.  I think I was the only one that believed her because she had to constantly defend herself on CNBC and Bloomberg.  Her calls on Tesla over the past year have been some of the best predictions I've ever seen regarding momentum growth stocks.

Tesla (TSLA) is now a strong buy below $200 if the stock ever sees another big correction.

Check out more hot stocks in 2014 - Stock Gainers 2014 - Penny Stocks Gainers 2014

Bank of America (BAC) Stock Analysis - Buy or Sell?

By Tim - http://stockstobuy.org

The following is technical analysis on Bank of America (BAC) - November 10, 2011

Bank of America (BAC) Support & Resistance Levels - 11/10/11

Resistance Levels: $7.00, $7.43

Support Levels: $5.50, $5.13

Chart - http://www.stockcharts.com

Bank of America (BAC) has been one of the worst performing large cap bank stocks in 2011. Do we buy, sell, or hold BAC stock into 2012? Bank of America (BAC) is now back testing levels we haven't seen since earnings day. I feel BAC stock is a buy below $6 for the long term but also think you should sell your BAC stock in the $7's. Bank of America (BAC) will have support around $5.50 on the downside over the next two weeks.

Discuss Stocks with other Traders - Sign Up Free

Today's Stock Gainers - Today's Stock Losers - 2012 Stock Picks - 2012 Penny Stocks - 2012 Stocks to Buy - Day Trading Tips - Stock Trading Rules

For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/

Green Mountain Coffee (GMCR) Stock Analysis

By Tim - http://stockstobuy.org

The following is technical analysis on Green Mountain Coffee Roasters Inc. (GMCR) - November 10, 2011

Green Mountain Coffee Roasters Inc. (GMCR) Support & Resistance Levels - 11/10/11

Resistance Levels: $48.04

Support Levels: $40.55, $40

Chart - http://www.stockcharts.com

Green Mountain Coffee Roasters Inc. (GMCR) stock is dropping hard today after the company saw weak orders during the quarter and continues to burn through cash. Green Mountain Coffee Roasters Inc. (GMCR) bounced near $40 this morning which is where I'd keep my stop right now. GMCR will have resistance up at $48.04 going forward.

Discuss Stocks with other Traders - Sign Up Free

Today's Stock Gainers - Today's Stock Losers - 2012 Stock Picks - 2012 Penny Stocks - 2012 Stocks to Buy - Day Trading Tips - Stock Trading Rules

For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/

OXiGENE, Inc (OXGN) Stock News: Restructuring

By Tim - http://stockstobuy.org

OXiGENE, Inc (OXGN) stock just dropped hard after the company came out with news of a restructuring plan. Shares of OXiGENE, Inc (OXGN) are currently trading at $1.14, Down 35%.

September. 1, 2011 - OXiGENE, Inc. (Nasdaq:OXGN - News), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today a restructuring plan designed to focus the Company's capital resources on its most promising early-stage clinical programs and further reduce its cash utilization. Key aspects of the restructuring and its effects on the Company's current and planned clinical trials are as follows:

• At this time, a Company sponsored Phase 3 registrational study of ZYBRESTAT in patients with anaplastic thyroid cancer (ATC) funded by Company financial resources is not feasible. OXiGENE will continue to explore options for conducting such a study, including potential collaborations with national and international head and neck cancer cooperative groups. Future development decisions concerning ZYBRESTAT in patients with ATC will be made following a review of all options by OXiGENE's management and its board of directors.

• OXiGENE is concluding its Phase 2 ZYBRESTAT trial in non-small cell lung cancer (FALCON study). At this time, no decision regarding further development of the study of ZYBRESTAT in patients with NSCLC has been made. Any future development decisions concerning the study of ZYBRESTAT in patients with NSCLC will be made following review of final data by OXiGENE's management and its board of directors.

• OXiGENE plans to continue its investigator-sponsored Phase 1 trial of OXi4503 in patients with AML or myelodysplastic syndrome (MDS), being conducted at the University of Florida and with support by The Leukemia & Lymphoma Society's Therapy Acceleration Program.

• OXiGENE plans to continue its randomized Phase 2 trial of ZYBRESTAT in combination with bevacizumab in patients with relapsed ovarian cancer, which is an NCI-sponsored study conducted by the Gynecologic Oncology Group (GOG), an organization dedicated to clinical research in the field of gynecologic cancer.

• OXiGENE will evaluate additional early-stage development opportunities for its two product candidates, ZYBRESTAT and OXi4503, subject to available resources at the time.

• The Company is reducing its workforce by 11 full-time equivalent employees or approximately 61%.

• The Company will seek to reduce the amount of space it currently rents to conduct its operations as soon as practicable.

Today's Biggest Stock Gainers - Top 2011 Stock Gainers - Top 2011 Penny Stock Gainers - Top 2010 Stock Gainers - Top 2010 Penny Stocks - Stocks for 2011

For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/

Clearwire (CLWR) Stock Technical Analysis

By Tim - http://stockstobuy.org

The following is technical analysis for Clearwire Corporation (CLWR) - September 1, 2011

Clearwire Corporation (CLWR) Support & Resistance Levels - 9/1/11

Resistance Levels: $4.18, $4.77

Support Levels: $3.42, $3.00

Chart - http://www.stockcharts.com

Clearwire Corporation (CLWR) is higher today on further speculation that Sprint (NYSE:S) and CLWR could get bought out. Sprint (S) controls 48% of Clearwire stock which has been depressed lately. CLWR is gapping above the previous $3.42 high this morning. If Clearwire closes above $3.42, I could see it testing $4.18 which is the next resistance.

Today's Biggest Stock Gainers - Top 2011 Stock Gainers - Top 2011 Penny Stock Gainers - Top 2010 Stock Gainers - Top 2010 Penny Stocks - Stocks for 2011

For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/

CIENA Corp. (CIEN) Stock Technical Analysis

By Tim - http://stockstobuy.org

The following is technical analysis for CIENA Corp. (CIEN) - September 1, 2011

CIENA Corp. (CIEN) Support & Resistance Levels - 9/1/11

Resistance Levels: $14

Support Levels: $12.50

Chart - http://www.stockcharts.com

CIENA Corp. (CIEN) stock is up today due to better than expected earnings. CIENA Corp. (CIEN) will have resistance located $13.49 as well as $14. If CIEN closes above $14, I could see the stock moving back up into the $16's eventually. CIEN will have support down at $12.50.

Today's Biggest Stock Gainers - Top 2011 Stock Gainers - Top 2011 Penny Stock Gainers - Top 2010 Stock Gainers - Top 2010 Penny Stocks - Stocks for 2011

For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/

Buy EnerNOC, Inc. (ENOC) Stock?

Tim, should I buy EnerNOC, Inc. (ENOC) stock on the rally today? By Tim - http://blackberrystocks.com

Thank You for the question. Shares of EnerNOC, Inc. (ENOC) are rallying off the recent lows but I wouldn't touch the stock for a long term buy just yet. Short term, ENOC could certainly have more upside to the $16-$17 range but I would think the shorts would come back and short the stock again. As you can see, EnerNOC, Inc. (ENOC) has been subject to a nasty downtrend over the past year. The stock has dropped from $36 all the way down to $8.39 recently.

Here is what I would do if I was thinking of buying ENOC. Keep an eye on the 200 day moving average ( currently $19.15 and dropping ). A great entry point for the long term would be to buy ENOC when the stock closes above this level. In technical analysis world, this would be a buy signal. If you see this buy signal happen, contact me again and I will do additional analysis.

http://daytradingstockblog.blogspot.com

Buy FiberTower Corporation (FTWR) Stock?

Tim, Should I buy FiberTower Corporation (FTWR) stock? By Tim - http://stockstobuy.org

Thanks for the question! FiberTower Corporation (FTWR) is an interesting company but has seen their stock drop off a cliff recently. FiberTower Corporation (FTWR) has been really showing strong revenue growth over the past 3 years but they continue to lose money.

FiberTower Corporation (FTWR) stock is up 37% to $1.11 this morning on no news. FiberTower Corporation (FTWR) is also trading back above the 50 day moving average located at $1.09. In the technical analysis world, this is normally a buy signal that traders look for in order to buy back into the stock. These same traders will probably be putting a tight stop order at $0.99.

I usually don't buy a stock unless it breaks previous significant highs. FTWR has resistance levels at $1.73 as well as $2.09.

For a quick trade, I plan to buy FTWR on a break above $1.73.

http://daytradingstockblog.blogspot.com